AAAAAA
Results: 26-48/48
Authors:
KOZA MJ
WALENGA JM
HOPPENSTEADT DA
BERMES EW
FAREED J
Citation: Mj. Koza et al., MEASUREMENT OF THE ANTICOAGULANT EFFECT OF WARFARIN IN THE PRESENCE OF AN ANTITHROMBIN AGENT USING AMIDOLYTIC FACTOR-X ASSAY, Clinical chemistry, 42(6), 1996, pp. 412-412
Authors:
IQBAL O
HOPPENSTEADT DA
KOZA MJ
BERMES EW
WALENGA JM
FAREED J
Citation: O. Iqbal et al., MOLECULAR MARKERS OF HEMOSTATIC AND VASCULAR ABBERATIONS IN THE ELDERLY AND THEIR PREDICTIVE VALUE FOR THE DIAGNOSIS OF THROMBOTIC DISORDERS, Clinical chemistry, 42(6), 1996, pp. 413-413
Authors:
FAREED J
BICK RL
HOPPENSTEADT DA
BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - APPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS AND VASCULAR AND THROMBOTIC DISORDERS, Clinical and applied thrombosis/hemostasis, 1(2), 1995, pp. 87-102
Authors:
HOPPENSTEADT DA
JESKE W
FAREED J
BERMES EW
Citation: Da. Hoppensteadt et al., THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN, Blood coagulation & fibrinolysis, 6, 1995, pp. 57-64
Authors:
FAREED J
BICK RL
HOPPENSTEADT DA
WALENGA JM
MESSMORE HL
BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - IMPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS, VASCULAR, AND CARDIOVASCULAR DISORDERS, Clinics in laboratory medicine, 15(1), 1995, pp. 39-61
Authors:
HOPPENSTEADT DA
FASANELLA A
FAREED J
Citation: Da. Hoppensteadt et al., EFFECT OF PROTAMINE ON HEPARIN-RELEASABLE TFPI ANTIGEN LEVELS IN NORMAL VOLUNTEERS, Thrombosis research, 79(3), 1995, pp. 325-330
Authors:
HOPPENSTEADT DA
WALENGA JM
FASANELLA A
JESKE W
FAREED J
Citation: Da. Hoppensteadt et al., TFPI ANTIGEN LEVELS IN NORMAL HUMAN VOLUNTEERS AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION OF UNFRACTIONATED HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN, Thrombosis research, 77(2), 1995, pp. 175-185
Authors:
HOPPENSTEADT DA
WALENGA JM
FAREED J
BERMES EW
Citation: Da. Hoppensteadt et al., COMPARING R-TISSUE FACTOR AND MAMMALIAN TISSUE REAGENTS FOR PROTHROMBIN TIME, Laboratory medicine, 26(3), 1995, pp. 198-203
Authors:
WALENGA JM
HOPPENSTEADT DA
GRYZBAC M
MAY K
BLAKEMORE C
MANABAT N
MOLNAR J
BERMES EW
Citation: Jm. Walenga et al., EVALUATION OF THE STA AUTOMATED ANALYZER FOR HEMOSTASIS TESTING, Blood, 86(10), 1995, pp. 3552-3552
Authors:
FASANELLA T
HOPPENSTEADT DA
FAREED J
WOLF H
Citation: T. Fasanella et al., INTRAVENOUS AND SUBCUTANEOUS PHARMACOKINETICS OF A LOW-MOLECULAR-WEIGHT HEPARIN (CERTOPARIN(R)) IN MAN, Blood, 86(10), 1995, pp. 3650-3650
Authors:
HOPPENSTEADT DA
BICK RL
JESKE W
NICOLAIDES AN
FAREED J
Citation: Da. Hoppensteadt et al., PHYSICAL AND PHARMACOLOGICAL MODULATION OF THE VASCULAR SYSTEM AS MEASURED BY THE RELEASE OF TFPI, NO, TPA, AND PROSTACYCLIN AS MARKERS OF ENDOTHELIAL STIMULATION, Blood, 86(10), 1995, pp. 3653-3653
Authors:
KAISER B
HOPPENSTEADT DA
JESKE W
WUN TC
FAREED J
Citation: B. Kaiser et al., INHIBITORY EFFECTS OF TFPI ON THROMBIN AND FACTOR XA GENERATION IN-VITRO - MODULATORY ACTION OF GLYCOSAMINOGLYCANS, Thrombosis research, 75(6), 1994, pp. 609-616
Authors:
FAREED J
PIFARRE R
LEYA F
HOPPENSTEADT DA
WALENGA JM
BICK RL
Citation: J. Fareed et al., PLATELET FACTOR-IV AND ANTITHROMBIN-III ARE NOT THE SOLE DETERMINANTSOF THE HEPARINIZATION RESPONSE, Circulation, 90(4), 1994, pp. 180-180
Authors:
FAREED J
PIFARRE R
LEYA F
HOPPENSTEADT DA
WALENGA JM
BICK RL
Citation: J. Fareed et al., PLATELET FACTOR-IV AND ANTITHROMBIN-III ARE NOT THE SOLE DETERMINANTSOF THE HEPARINIZATION RESPONSE, Circulation, 90(4), 1994, pp. 180-180
Authors:
HOPPENSTEADT DA
FAREED J
JESKE W
LEYA F
KOZA MJ
WALENGA JM
PIFARRE R
Citation: Da. Hoppensteadt et al., RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR AS AN ANTITHROMBOTIC AND ANTICOAGULANT AGENT FOR INTERVENTIONAL CARDIOVASCULAR INDICATIONS, Blood, 84(10), 1994, pp. 10000067-10000067
Authors:
FAREED J
HOPPENSTEADT DA
WALENGA JM
Citation: J. Fareed et al., CURRENT PERSPECTIVES ON LOW-MOLECULAR-WEIGHT HEPARINS, Seminars in thrombosis and hemostasis, 19, 1993, pp. 1-11
Authors:
HOPPENSTEADT DA
JESKE W
AHSAN A
WALENGA JM
FAREED J
Citation: Da. Hoppensteadt et al., BIOCHEMICAL AND PHARMACOLOGICAL PROFILE OF DEFINED MOLECULAR-WEIGHT FRACTIONS OF HEPARIN, Seminars in thrombosis and hemostasis, 19, 1993, pp. 12-19
Authors:
HOPPENSTEADT DA
HAAS S
BREDDIN HK
FAREED J
Citation: Da. Hoppensteadt et al., MODULATION OF LABORATORY PARAMETERS AFTER THERAPEUTIC AND PROPHYLACTIC ADMINISTRATION OF SANDOPARIN, Seminars in thrombosis and hemostasis, 19, 1993, pp. 31-35
Authors:
LOJEWSKI B
BACHER P
IQBAL O
WALENGA JM
HOPPENSTEADT DA
LEYA F
FAREED J
Citation: B. Lojewski et al., EVALUATION OF HEMATOLOGIC ALTERATIONS ASSOCIATED WITH DAILY ADMINISTRATION OF LOW-MOLECULAR-WEIGHT HEPARIN (MONO-EMBOLEX) FOR A 12-WEEK PERIOD, Seminars in thrombosis and hemostasis, 19, 1993, pp. 36-43
Authors:
CALLAS DD
HOPPENSTEADT DA
JESKE W
IQBAL O
BACHER P
AHSAN A
FAREED J
Citation: Dd. Callas et al., COMPARATIVE PHARMACOLOGICAL PROFILE OF A GLYCOSAMINOGLYCAN MIXTURE, SULODEXIDE, AND A CHEMICALLY-MODIFIED HEPARIN DERIVATIVE, SULEPAROIDE, Seminars in thrombosis and hemostasis, 19, 1993, pp. 49-57
Authors:
MALINOWSKA K
IQBAL O
HOPPENSTEADT DA
WALENGA JM
FAREED J
Citation: K. Malinowska et al., INVIVO STUDY OF BLEEDING AND ANTITHROMBOTIC EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN ML-009723, Seminars in thrombosis and hemostasis, 19, 1993, pp. 58-62
Authors:
BACHER P
HORST B
BREYER HG
HOPPENSTEADT DA
WALENGA JM
FAREED J
Citation: P. Bacher et al., POSTOPERATIVE MONITORING OF LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS IN HIGH-RISK PATIENTS, Seminars in thrombosis and hemostasis, 19, 1993, pp. 73-78
Authors:
IQBAL O
JESKE W
BACHER P
HOPPENSTEADT DA
WALENGA JM
FAREED J
Citation: O. Iqbal et al., A COMPARISON OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF CLEXANE AND LOVENOX IN DOGS, Seminars in thrombosis and hemostasis, 19, 1993, pp. 199-209